Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Sanchez

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Eclinicalmedicine|January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Movement Disorders Clinical Practice|December 22, 2025
Validation of the German Version of the Movement Disorder Society Non-Motor Scale (MDS-NMS)Jonas Bendig, Anika Frank, Adrianna Lipska-Dieck, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Epilepsy & Behavior : E&B|November 3, 2022
Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsyVicente Villanueva, Adrián García-Ron, Patricia Smeyers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2025
Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic ReviewSasivimol Virameteekul, Chaewon Shin, Siegfried S Hirczy, et al.
Clinical Parkinsonism & Related Disorders|January 21, 2026
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleGuido Alves, Yvonne Stavland Sørenes, Veslemøy Hamre Frantzen, et al.
BMC Women'S Health|January 29, 2026
Improvement in health‑related quality of life in patients with heavy menstrual bleeding after treatment and its association with hereditary bleeding disordersM A Cabrero Segurado, J M Bastida, C Gilabert, et al.
Neurologia I Neurochirurgia Polska|August 6, 2025
Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS)Joanna Siuda, Mateusz Toś, Tomasz Chmiela, et al.
Msystems|October 10, 2019
Current State of and Future Opportunities for Prediction in Microbiome Research: Report from the Mid-Atlantic Microbiome Meet-up in Baltimore on 9 January 2019Eric Sakowski, Gherman Uritskiy, Rachel Cooper, et al.
Epilepsy & Behavior : E&B|November 3, 2021
COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter studyAlvaro Sanchez-Larsen, Estefanía Conde-Blanco, Alejandro Viloria-Alebesque, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Eclinicalmedicine|January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Movement Disorders Clinical Practice|December 22, 2025
Validation of the German Version of the Movement Disorder Society Non-Motor Scale (MDS-NMS)Jonas Bendig, Anika Frank, Adrianna Lipska-Dieck, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking <i>C9ORF72</i>-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Epilepsy & Behavior : E&B|November 3, 2022
Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsyVicente Villanueva, Adrián García-Ron, Patricia Smeyers, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2025
Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic ReviewSasivimol Virameteekul, Chaewon Shin, Siegfried S Hirczy, et al.
Clinical Parkinsonism & Related Disorders|January 21, 2026
Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating ScaleGuido Alves, Yvonne Stavland Sørenes, Veslemøy Hamre Frantzen, et al.
BMC Women'S Health|January 29, 2026
Improvement in health‑related quality of life in patients with heavy menstrual bleeding after treatment and its association with hereditary bleeding disordersM A Cabrero Segurado, J M Bastida, C Gilabert, et al.
Neurologia I Neurochirurgia Polska|August 6, 2025
Validation of the Polish version of the Movement Disorder Society Non-motor Rating Scale (MDS-NMS)Joanna Siuda, Mateusz Toś, Tomasz Chmiela, et al.
Msystems|October 10, 2019
Current State of and Future Opportunities for Prediction in Microbiome Research: Report from the Mid-Atlantic Microbiome Meet-up in Baltimore on 9 January 2019Eric Sakowski, Gherman Uritskiy, Rachel Cooper, et al.
Epilepsy & Behavior : E&B|November 3, 2021
COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter studyAlvaro Sanchez-Larsen, Estefanía Conde-Blanco, Alejandro Viloria-Alebesque, et al.
Pageof 26